A case of acute myocarditis induced by PD-1 inhibitor (sintilimab) in the treatment of large cell neuroendocrine carcinoma

The combination of Sintilimab with pemetrexed/platinum has become the first-line treatment for non-squamous non-small-cell lung carcinoma (NSCLC). Here, we report a patient with metastatic large cell neuroendocrine carcinoma (LCNEC) treated with Sintilimab for five cycles who developed shortness of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Siming, Zhang, Haiyu, Hu, Bingshuang, Zhou, Jiaxiong, Wen, Lei, Li, Minying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277459/
https://www.ncbi.nlm.nih.gov/pubmed/37342584
http://dx.doi.org/10.1016/j.heliyon.2023.e16874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277459/
https://www.ncbi.nlm.nih.gov/pubmed/37342584
http://dx.doi.org/10.1016/j.heliyon.2023.e16874

Ejemplares similares